Quantcast

Industry news that matters to you.  Learn more

KalGene Pharmaceuticals, Sunnybrook Research Institute, Ontario Cancer Biomarker Network and CIMTEC Announce Multi-year Collaboration to Tackle Aggressive Cancers

KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion therapeutic that specifically targets aggressive cancers.